6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
12m ago	FatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
39m ago	Angle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
39m ago	Century Complete Announces New Homes Coming Soon to Fleming Island, FL
39m ago	Sprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
40m ago	Tambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

About

Arbutus Biopharma Corp (NASDAQ:ABUS) — investor relations, events, news, and company updates on 6ix.

Latest News

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B

Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025

Financials

Revenue

$14.08 M

Market Cap

$875.74 M

EPS

-0.17

Community Chat

Ask AI